Compound to Control Presbyopia Symptoms
Study Details
Study Description
Brief Summary
Low dose compose to control presbyopia symptoms
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Phase 1 |
Detailed Description
A los dose compound including pilocarpine, brimonidine and oxymetazoline was use to control presbyopia symptoms compared to pilocarpine and brimonidine in low doses.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: PBO Investigational drug Pilocarpine, brimonidine, oxymetazoline combined with hyaluronic acid and bromfenac combined in an ophthalmic solution to be randomly instilled in one eye. |
Combination Product: PBO to control presbyopia symptoms
Low dose PBO to control presbyopia symptoms
Other Names:
|
Active Comparator: Pilocarpine Pilocarpine was instilled in the other oye. |
Combination Product: PBO to control presbyopia symptoms
Low dose PBO to control presbyopia symptoms
Other Names:
|
Active Comparator: Brimonidine Brimonidine was instilled in the other eye. |
Combination Product: PBO to control presbyopia symptoms
Low dose PBO to control presbyopia symptoms
Other Names:
|
Outcome Measures
Primary Outcome Measures
- Jaeger notation near uncorrected visual acuity change [1 hour]
Number of lines improved 1 hour after drug instillation
- Comparison of PBO compound Jaeger notation improvement vs Pilocarpine or Brimonidine alone [1 hour]
Number of lines improve comparing PBO compound vs Pilocarpine or Brimonidine
Eligibility Criteria
Criteria
Inclusion Criteria:
-
healthy
-
Presbyopic
-
40 - 59 years
Exclusion Criteria:
-
Diabetics
-
Previous eye surgery
-
Previous eye disease
-
0.50 myopia
-
1.5 hyperopia or astigmatism
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Optall Vision | Mexico City | Mexico | 01090 |
Sponsors and Collaborators
- Optall Vision
Investigators
- Principal Investigator: Cesar Alejandro S Galeana, Optall Vision
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- PBOPC01